Chaperon Inc. will begin offering a new service, "Shaperon Materials Review AI (beta version)," in April 2025. This service is a solution that uses AI to analyze table data, graphs, images, and text to automatically review promotional materials used by pharmaceutical companies. As regulations become stricter and promotion becomes more digital, pharmaceutical companies are facing the challenge of balancing stricter review and monitoring with the rapid dissemination of information. In particular, the increasing volume of digital content and materials, including figures, graphs, and images, requires a lot of manpower and time to review, which often becomes a bottleneck in the rapid dissemination of information. We have supported the efficiency of monitoring and reviewing text information through services such as "Monitoring AI". However, the following challenges remain in the review work…
Otsuka Shokai Co. Ltd. announced that it will start offering "Tayoreru EDR Advisory Service for…
Telexistence Inc. has joined the AI Robot Association as a board member and has begun…
In GovTech news this week… 🔹 Plus and TIER IV Partner to Advance Autonomy 2.0…
Amazon Web Services (AWS) has launched its new quantum computing chip, "Ocelot." This move puts…
Mitsubishi Logistics Corporation, Mitsubishi Corporation, and Yourstand Inc. are set to introduce medium-sized EV trucks starting in March 2025 to…
GiftPad Inc., which supports digital transformation for local governments and companies, is pleased to announce that the number of users…
Nippon Brace Co., Ltd. has announced "MEDIX-R", a self-training and medical support platform compatible with smart glasses and Android devices,…
NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc., a U.S.-based provider of…
Cardinal Health Inc. began selling the Kangaroo OMNI Pump, a state-of-the-art enteral nutrition pump that can be used with high-viscosity…
Agatica Inc., which promotes cashless medical care, is pleased to announce that it has raised a total of 45.8 million…
JiMED Inc., a developer of wireless implantable BMI system medical devices, has raised a total of 350 million yen through…
Boston Medical Sciences Co., Ltd. is pleased to announce that it has raised 930 million yen in a Series A…
Sign in to your account